Production (Stage)
Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.60% | -3.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.60% | -3.81% | |||
| Cost of Revenue | -1.61% | -10.87% | |||
| Gross Profit | -1.59% | -0.33% | |||
| SG&A Expenses | -1.58% | -10.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -1.92% | -- | |||
| Total Operating Expenses | -1.58% | -5.47% | |||
| Operating Income | 1.62% | 9.43% | |||
| Income Before Tax | 1.58% | -136.35% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.58% | -136.35% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.58% | -136.35% | |||
| EBIT | 1.62% | 9.43% | |||
| EBITDA | -0.88% | 5.98% | |||
| EPS Basic | 0.00% | -100.00% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | 0.00% | -100.00% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||